InterventionsReview
Innovative holistic treatment for CKM: what lies ahead?

European Journal of Internal Medicine
- GLP-1 receptor agonists
- Lifestyle modification
- Non-steroidal mineralocorticoid receptor antagonists
- Cardiovascular-kidney-metabolic syndrome
- Metabolic dysfunction-associated steatotic liver disease
- Albuminuria
The paper
Paul Balfanz, Nikolaus Marx
University Hospital RWTH Aachen - Department of Cardiology
European Journal of Internal Medicine · 5 Oct 2026

